DexCom Announces Upcoming Conference Presentation
January 29 2016 - 8:30AM
Business Wire
DexCom, Inc. (NASDAQ:DXCM) today announced that management will
present an update on DexCom at the following upcoming investor
conference:
- Steven Pacelli, Executive Vice
President, Strategy and Corporate Development, will present an
update on the company at the Leerink Partners 5th Annual Global
Healthcare Conference in New York City, New York on Thursday,
February 11, 2016 at 10:45am (EST). The presentation, which will
occur live at the Waldorf Astoria Hotel, will be concurrently
webcast.
The link to the webcast will be available on the DexCom website
at www.dexcom.com by navigating to “Our Company,” then “Investor
Relations,” and finally “Events and Webcasts” and will be archived
there for future reference.
About DexCom, Inc.
DexCom, Inc., headquartered in San Diego, California, is
developing and marketing continuous glucose monitoring systems for
ambulatory use by patients and by healthcare providers in the
hospital.
Cautionary Statement Regarding Forward Looking
Statements
DexCom is a medical device company with a limited operating
history. Successful commercialization of the company's products is
subject to numerous risks and uncertainties, including a lack of
acceptance in the marketplace by physicians and patients, the
inability to manufacture products in commercial quantities at an
acceptable cost, possible delays in the company's development
programs, the inability of patients to receive reimbursement from
third-party payors and inadequate financial and other resources.
Certain of these risks and uncertainties, in addition to other
risks, are more fully described in the company's annual report on
Form 10-K for the year ended December 31, 2014, as filed with the
Securities and Exchange Commission on February 25, 2015.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160129005094/en/
DexCom, Inc.Steven R. PacelliExecutive Vice President,
Strategy and Corporate Development(858) 200-0200
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From Mar 2024 to Apr 2024
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From Apr 2023 to Apr 2024